Episode 38 Why Cancer Keeps Winning: Randall Riggs on drug failure, mutation, and limits of progress

from The Innovation Blueprint · host Webisoft

30 years in pharma and one approved drug says everything. Randall B. Riggs breaks down why cancer resists even the best science, how mutation outpaces static treatments, and why resilience matters more than breakthroughs. Progress is real, but the odds, funding gaps, and biology keep the fight brutally uneven.

Episode metadata supplied by the publisher feed · Published Jun 11, 2026

Embed this episode

Attribution link and audio player

Ready to play

Episode 38 Why Cancer Keeps Winning: Randall Riggs on drug failure, mutation, and limits of progress

0:00 32:27

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Innovation Blueprint?

This episode is 32 minutes long.

When was this The Innovation Blueprint episode published?

This episode was published on June 11, 2026.

Can I download this The Innovation Blueprint episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!